Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study page now states it is no longer recruiting participants and adds sections on reading the study record, common questions, and how to join. Formatting for the Intervention/Treatment heading was adjusted and the revision note updated to v3.6.0.SummaryDifference0.3%

- Check18 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision was recorded.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision line was updated from Revision: v3.5.3 to Revision: v3.5.4, indicating an administrative update to the page metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s platform/version indicator has been updated from Revision: v3.5.2 to Revision: v3.5.3.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.